前列舒宁方治疗慢性前列腺炎临床观察  

Clinical Observations on Treatment of 120 Chronic Prostatitis Patients with Qianllieshuning Decoction

作　　者：张凯麟[1] 汪皓[1] 

机构地区：[1]甘肃省天水市第一人民医院,甘肃天水741000

出　　处：《中国医学创新》2013年第10期22-24,共3页Medical Innovation of China

摘　　要：目的:观察自拟前列舒宁方治疗慢性前列腺炎的临床疗效。方法:120例随机分为治疗组和对照组,治疗组80例服用前列舒宁方,服法1日1剂,分2次煎,汁500ml,3次/d;对照组40例,服前列通瘀胶囊,5粒/次,3次/d。1个月为一疗程,连续服药治疗2个疗程,并坚持随访1个月。观察治疗前后临床症状及EPS-WBC、EPS-卵磷脂小体数、NIH-CPSI各项评分等的变化。结果:治疗组对临床症状及EPS-WBC、EPS-卵磷脂小体数、NIH-CPSI各项评分等有明显改善,治疗组的总有效率为93.75%,优于对照组的80%(P<0.005),未发现有任何不良反应。结论:前列舒宁方治疗慢性前列腺炎的疗效明显优于传统的对症治疗药物,具有较好的治疗依从性,为慢性前列腺炎的治疗提供了一条新途径。Objective： To observe the clinical efficacy of Qianllieshuning Decoction on chronic prostatitis patients. Method： 120 cases were randomly divided into treatment group and control group, 80 patients in group were treated with the Qianllieshuning Decoction, Daily pay, decoction secondary decoction 500 ml Dosage 3 times a day; control group in which 40 cases were treated with Qianlietongyu Capsules, 3 times a day, 5 pills each times. A month for a course, and lasted for 2 courses. All cases were foUowed-up for more than 1 month. The clinical symptoms and the score of EPS-the WBC, the body of the EPS-lecithin, the NIH-CPSI were observed. Result： The clinical symptoms and the score of EPS-the WBC, number of EPS-lecithin, the NIH-CPSI improved significantly, The total effective rate was 93.75% in the treatment group higher than that of the control group , The total effective rate of which was 80% （P 〈0.005 ）, No abnormal reaction was observed. Conclusion： The Qianllieshuning Decoction is superior to traditional drugs for treatment chronic prostatitis. A new medicine was found out for the treatment of chronic prostatitis.

关 键 词：前列舒宁方 慢性前列腺炎 临床疗效 

分 类 号：R277.5[医药卫生—中医学]